文献速递神经介入DSA

新型血流导向装置(Tubridge)治疗复发性动脉瘤的单中心经验

A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience.
PubMed 文献 · Korean J Radiol · 2017-07-17

单中心前瞻性数据库分析8例复发性动脉瘤患者(8个动脉瘤,平均大小16.7 mm),既往治疗为1个弹簧圈栓塞和7个单支架辅助弹簧圈栓塞,采用Tubridge血流导向装置(6个单用,2个联合弹簧圈)治疗;无重大缺血或出血并发症,1例发生血管痉挛;随访7个动脉瘤(平均16.9个月),5个完全闭塞,2个残留瘤颈,1例椎动脉夹层动脉瘤载瘤动脉出现严重无症状狭窄,覆盖分支均通畅,所有患者改良Rankin量表评分≤2。作者认为在选定患者中Tubridge FD可为复发性动脉瘤再治疗提供安全有效的选择,但应注意若干技术要点。

要点

  • Tubridge FD治疗复发性动脉瘤:随访7个动脉瘤中5个完全闭塞,2个残留瘤颈。
  • 无重大缺血或出血并发症,1例发生血管痉挛,1例载瘤动脉严重无症状狭窄。
  • 所有被FD覆盖的可见分支均保持通畅,所有患者改良Rankin量表评分≤2。

核心结论

  • 在选定患者中,Tubridge FD可为复发性动脉瘤的再治疗提供安全有效的选择,但应注意若干技术要点。

研究设计与样本

  • 单中心前瞻性数据库回顾性分析,纳入8例患者8个复发性动脉瘤(平均大小16.7 mm),其中4个既往破裂;既往治疗为1个弹簧圈栓塞和7个单支架辅助弹簧圈栓塞;6个动脉瘤单用Tubridge FD治疗,2个采用FD联合弹簧圈治疗;分析操作并发症及临床和血管造影结果。

关键影像表现/征象

  • 8个动脉瘤术后即刻血管造影均显示不完全闭塞。
  • 随访7个动脉瘤(平均16.9个月,范围7-36个月),5个完全闭塞,2个残留瘤颈。
  • 1例椎动脉夹层动脉瘤的载瘤动脉出现严重无症状狭窄。
  • 所有被FD覆盖的可见分支均保持通畅。

诊断标准与关键数值

  • 动脉瘤闭塞程度评估:完全闭塞5个,残留瘤颈2个(随访7个动脉瘤)。
  • 临床结局采用改良Rankin量表评分≤2定义为良好结局,所有患者在出院和随访时均达到。

临床应用与阅片要点

  • 作者认为在选定患者中Tubridge FD可为复发性动脉瘤再治疗提供安全有效的选择。
  • 作者指出应注意若干技术要点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The Tubridge flow diverter (FD) is a novel device aimed at reconstructing the parent artery and occluding complex aneurysms. Retreatment of recurrent aneurysms using the FD is challenging. We report our initial experience in the repair of aneurysm recurrence with the FD.

MATERIALS AND METHODS: A database was reviewed prospectively, and 8 patients with 8 recurrent aneurysms (mean size, 16.7 mm) were identified. Four aneurysms had previously ruptured. The previous aneurysm treatment consisted of coiling in 1 aneurysm and single-stent-assisted coiling in 7 aneurysms. The procedural complications and clinical and angiographic outcomes were analyzed.

RESULTS: Six aneurysms were treated by using a single Tubridge FD alone, while the remaining 2 were treated with FD + coiling. The immediate results of the 8 aneurysms were that they all showed incomplete occlusion. Neither major ischemic nor hemorrhagic complications occurred; however, 1 patient experienced a vasospasm. Follow-up angiographies were available for 7 aneurysms; the mean follow-up was 16.9 months (7-36 months). Five aneurysms were completely occluded, whereas 2 had a residual neck. Severe asymptomatic stenosis of 1 parent artery of a vertebral artery dissecting aneurysm was found. All visible branches covered by the FD were patent. All patients were clinically assessed as having attained a favorable outcome (modified Rankin Scale score ≤ 2) at discharge and follow-up.

CONCLUSION: In selected patients, the Tubridge FD can provide a safe and efficient option for the retreatment of recurrent aneurysms. Nevertheless, attention should be paid to several technical points.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Huang QH, Fang Y, et al. A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience. Korean J Radiol. 2017. PMID: 28860903. doi:10.3348/kjr.2017.18.5.852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。